Cargando…
Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer
Antibodies are widely available and cost-effective research tools in life science, and antibody conjugates are now extensively used for targeted therapy, immunohistochemical staining, or in vivo diagnostic imaging of cancer. Significant advances in site-specific antibody labeling technologies have e...
Autores principales: | Knutson, Steve, Raja, Erum, Bomgarden, Ryan, Nlend, Marie, Chen, Aoshuang, Kalyanasundaram, Ramaswamy, Desai, Surbhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918962/ https://www.ncbi.nlm.nih.gov/pubmed/27336622 http://dx.doi.org/10.1371/journal.pone.0157762 |
Ejemplares similares
-
Antibody drug conjugates: hitting the mark in pancreatic cancer?
por: Wittwer, Nicole L., et al.
Publicado: (2023) -
HMGB1: A Promising Therapeutic Target for Prostate Cancer
por: Gnanasekar, Munirathinam, et al.
Publicado: (2013) -
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021) -
Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation
por: Christie, R. James, et al.
Publicado: (2017) -
Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017)